Itraconazole Alters the Stem Cell Characteristics of A549 and NCI-H460 Human Lung Cancer Cells by Suppressing Wnt Signaling

作者: Chuanhui Chen , Wei Zhang

DOI: 10.12659/MSM.919347

关键词:

摘要: BACKGROUND Cancer stem cells (CSCs) behave as their malignant counterparts, but persist after treatment, and possess properties that allow them to interact with environment. Itraconazole, an antifungal agent, also has a role in suppressing tumor progression, its effects regulating cell stemness remain unclear. This study aimed evaluate the of itraconazole on A549 NCI-H460 human lung cancer vitro. MATERIAL AND METHODS BEAS-2B normal bronchial epithelial were cultured without itraconazole. Cell viability was evaluated. The expression markers, CD133, ATP binding cassette subfamily G member 2 (ABCG2), aldehyde dehydrogenase 1 (ALDH1), measured by Western blot quantitative real-time polymerase chain reaction (qRT-PCR). Sphere-forming evaluated RESULTS Itraconazole reduced molecules ABCG2, ALDH1 cells, numbers sphere-forming reduced. However, had little effect enhanced chemosensitivity cells. inhibited Wnt signaling. Re-activation signaling restored itraconazole-mediated inhibition stemness. CONCLUSIONS altered characteristics did not affect viability.

参考文章(23)
Junyi Zhang, Rongcheng Luo, Rong Li, Zhiyue Liu, Hongying Qu, Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review. International Journal of Clinical and Experimental Pathology. ,vol. 6, pp. 2644- 2650 ,(2013)
Ya-peng Hu, Li-yang Tao, Fang Wang, Jian-ye Zhang, Yong-ju Liang, Li-wu Fu, Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2 Biochemical Pharmacology. ,vol. 85, pp. 1619- 1625 ,(2013) , 10.1016/J.BCP.2013.04.003
A Eramo, F Lotti, G Sette, E Pilozzi, M Biffoni, A Di Virgilio, C Conticello, L Ruco, C Peschle, R De Maria, Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death & Differentiation. ,vol. 15, pp. 504- 514 ,(2008) , 10.1038/SJ.CDD.4402283
G. Bertolini, L. Roz, P. Perego, M. Tortoreto, E. Fontanella, L. Gatti, G. Pratesi, A. Fabbri, F. Andriani, S. Tinelli, E. Roz, R. Caserini, S. Lo Vullo, T. Camerini, L. Mariani, D. Delia, E. Calabro, U. Pastorino, G. Sozzi, Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 16281- 16286 ,(2009) , 10.1073/PNAS.0905653106
Anna Golebiewska, Nicolaas H.C. Brons, Rolf Bjerkvig, Simone P. Niclou, Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research Cell Stem Cell. ,vol. 8, pp. 136- 147 ,(2011) , 10.1016/J.STEM.2011.01.007
YING TANG, JINGMING HOU, GUANGHUI LI, ZONGCHANG SONG, XIAOJING LI, CUI YANG, WENYING LIU, YIDE HU, YU XU, ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines. Oncology Reports. ,vol. 32, pp. 2168- 2174 ,(2014) , 10.3892/OR.2014.3470
Guanzhao Liang, Musang Liu, Qiong Wang, Yongnian Shen, Huan Mei, Dongmei Li, Weida Liu, Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways Oncotarget. ,vol. 8, pp. 28510- 28525 ,(2017) , 10.18632/ONCOTARGET.15324
Cristina Alguacil-Núñez, Inés Ferrer-Ortiz, Elena García-Verdú, Pilar López- Pirez, Irene Maria Llorente-Cortijo, Bruno Sainz, Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts Critical Reviews in Oncology Hematology. ,vol. 125, pp. 102- 110 ,(2018) , 10.1016/J.CRITREVONC.2018.02.015
Min-Bin Chen, Yuan-Yuan Liu, Zhao-Yu Xing, Zhi-Qing Zhang, Qin Jiang, Pei-Hua Lu, Cong Cao, Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK Activation Molecular Cancer Therapeutics. ,vol. 17, pp. 1229- 1239 ,(2018) , 10.1158/1535-7163.MCT-17-1094